Effect of Zusanli acupoint injection of anisodamine on postoperative recovery quality of patients undergoing laparoscopic sleeve gastrectomy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300073705

Enrollment

Unknown

Registered

2023-07-19

Start date

2023-07-20

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic disease

Interventions

Group S ( Zusanli acupoint injection of anisodamine group ):After general anesthesia, 5mg ( 1ml ) of anisodamine sodium chloride solution was injected into Zusanli ( ST 36 ) on both sides.

Group P ( Zusanli acupoint injection of normal saline group ):After general anesthesia, 1ml normal saline was injected into Zusanli acupoints on both sides.

Group C ( Blank control group ):There is no special intervention.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1, patients undergoing laparoscopic sleeve gastrectomy ; 2, informed consent, voluntary participants in this experiment ; 3, ASA grade II-III ; 4,35kg / m2 = BMI = 50kg / m2 ; 5, aged 18-65 years, with normal communication.

Exclusion criteria

Exclusion criteria: 1, acupoint injection contraindications ( very weak constitution, frequent history of fainting, severe local skin infection of acupoint injection, etc. ) ; 2, allergic to anisodamine ; 3, with a history of upper abdominal surgery ; 4, patients with central nervous system or mental illness and preoperative use of mental related drugs ; 5, patients with severe heart, liver and kidney dysfunction ; 6, refused to sign the informed consent ; 7, while participating in other experimenters.

Design outcomes

Primary

Measure	Time frame
Quality of postoperative recovery;	—

Secondary

Measure	Time frame
Quality of postoperative recovery;Plasma interleukin 6;plasma substance P;serum motilin;postoperative nausea and vomiting;postoperation pain;Postoperative analgesic drug dosage;The first ambulation time after operation;The first postoperative exhaust time;	—

Countries

China

Contacts

Public ContactZhiping Wang

Affiliated Hospital of Xuzhou Medical University

zhpsqxt@126.com+86 133 3878 7071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026